Solitaire Biotech Pvt Ltd
About Solitaire Biotech Pvt Ltd
Data last updated:
Solitaire Biotech Pvt Ltd is a private limited company based in Chandigarh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 March 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24231CH2006PTC029857. Its GSTIN is 06AAKCS1763K1Z1 (Haryana).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Arun Kumar Gupta and Savitri Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at SCO 42 44 Sector 17 Chandigarh, Chandigarh, India.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.06 Cr, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹61,754 (net margin 0.6%) and EBITDA of ₹2.43 Lakh (EBITDA margin 2.3%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 6% over five years.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Solitaire Biotech Pvt Ltd's registered office is in Chandigarh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSCO 42 44 Sector 17 Chandigarh, Chandigarh, India
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Solitaire Biotech Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Solitaire Biotech is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Solitaire Biotech Pvt Ltd, buy the company report.
Financials of Solitaire Biotech Pvt Ltd
FY 2025 filings availableSolitaire Biotech Pvt Ltd reported revenue of ₹1.06 Cr (down 11% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 6% over five years, including a 11% fall in the latest year. EBITDA rose 68% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.43 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹61,754 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.3% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Solitaire Biotech Pvt Ltd, buy the company report.
Board of directors of Solitaire Biotech Pvt Ltd
Solitaire Biotech has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arun Kumar Gupta | Director | 08 Mar 2006 | 20 Years 8 Months | Current |
| Savitri Gupta | Director | 08 Mar 2006 | 20 Years 8 Months | Current |
Peer comparison
Solitaire Biotech Pvt Ltd is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Clinical Sleep and Respiratory Solutions Private Limited | ₹1.06 Cr (FY 2024) | -3.0% | Bangalore, Karnataka, India | |||
| Jaft Biotech Private Limited | ₹1.06 Cr (FY 2025) | 16.0% | New Delhi, Delhi, India | |||
| Vetlink Pharma Private Limited | ₹1.06 Cr (FY 2025) | 0.0% | Lucknow, Uttar Pradesh, India | |||
| Solitaire Biotech Pvt Ltdthis company | ₹1.06 Cr (FY 2024) | ₹61,754 | 0.6% | -11.0% | Chandigarh, India | |
| Astracure Lifesciences Private Limited | ₹1.06 Cr (FY 2025) | 41.0% | Siliguri, West Bengal, India | |||
| Spar Labs Private Limited | ₹1.05 Cr (FY 2025) | -73.0% | Hyderabad, Telangana, India | |||
| Valentis Life Science Private Limited | ₹1.05 Cr (FY 2024) | 108.0% | Ahmedabad, Gujarat, India | |||
| Biomedicare Laboratories Private Limited | ₹1.05 Cr (FY 2024) | -42.0% | New Delhi, Delhi, India |
To see the full peer comparison of Solitaire Biotech Pvt Ltd, buy the company report.
Auditor
Solitaire Biotech Pvt Ltd is audited by AMITKUMARARORA for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AMITKUMARARORA | FY 2023 | 096831 |
Shareholding
The shareholding of Solitaire Biotech Pvt Ltd is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Solitaire Biotech Pvt Ltd, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Jul 2025 | 101165304 | Canara Bank | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Solitaire Biotech Pvt Ltd are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Solitaire Biotech Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Solitaire Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAKCS1763K1Z1 | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Solitaire Biotech Pvt Ltd, buy the company report.
Recent activity
Solitaire Biotech Pvt Ltd has 3 board changes on record since 2006: 2 appointments and 1 cessation. The latest: Dharam Paul Gupta ceased to be Director on 03 Feb 2024.
Frequently asked questions
Solitaire Biotech is an active private limited company based in Chandigarh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 March 2006 (20+ years old) and is registered under CIN U24231CH2006PTC029857.
Solitaire Biotech has 2 current directors:
- Arun Kumar Gupta - Director
- Savitri Gupta - Director
The latest financial statements of Solitaire Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Solitaire Biotech is 06AAKCS1763K1Z1, registered in Haryana.
The CIN (Corporate Identification Number) of Solitaire Biotech is U24231CH2006PTC029857. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Solitaire Biotech was incorporated on 08 March 2006, making it 20+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Solitaire Biotech by revenue are Clinical Sleep and Respiratory Solutions Private Limited, Jaft Biotech Private Limited, Vetlink Pharma Private Limited, Astracure Lifesciences Private Limited, Spar Labs Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Dharam Paul Gupta ceased to be Director on 03 Feb 2024. Arun Kumar Gupta was appointed as Director on 08 Mar 2006. Savitri Gupta was appointed as Director on 08 Mar 2006.
The registered office of Solitaire Biotech is at SCO 42 44 Sector 17 Chandigarh, Chandigarh, India.
Solitaire Biotech operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Solitaire Biotech has open charges of ₹10 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
